Milae Bioresources Co., Ltd. (KOSDAQ:218150)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,834.00
-59.00 (-3.12%)
At close: Oct 8, 2026

Milae Bioresources Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9,5516,1084,8351,9927,55218,149
Short-Term Investments
5,21510,2249,36223,26219,8409,562
Cash & Short-Term Investments
14,76616,33214,19725,25427,39227,711
Cash Growth
8.11%15.04%-43.78%-7.80%-1.15%114.03%
Accounts Receivable
10,0608,23411,9787,3868,9918,446
Other Receivables
73.5688.42141.71440.12251.3163.25
Receivables
10,1348,32312,1367,8269,2958,562
Inventory
8,3166,3646,4424,3355,1165,103
Prepaid Expenses
8.934.648.817.338.477.63
Other Current Assets
608.67566.59333.71512.98159.93139.92
Total Current Assets
33,83331,59033,11737,93541,97241,524
Property, Plant & Equipment
20,68919,67721,09811,19111,38711,436
Long-Term Investments
----2.08498.97
Goodwill
4,1614,1615,7771,2291,5861,156
Other Intangible Assets
2,9403,1423,412178.6239.66407.66
Long-Term Accounts Receivable
000-0-00
Long-Term Deferred Tax Assets
---483.05397.91157.26
Other Long-Term Assets
456.85377.58503.78573.96510.51210.88
Total Assets
62,08058,96463,90951,59156,09555,390

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4,8043,6733,2081,9802,1623,290
Accrued Expenses
484.16491.57320.27209.53223.79185.73
Short-Term Debt
8,5808,3869,9312,68610,1982,322
Current Portion of Long-Term Debt
598.1598.1872.5550550-
Current Portion of Leases
183.73195.55220.39194.91246.56192.57
Current Income Taxes Payable
223.65107.12279.97-123.22-
Other Current Liabilities
4,7981,5432,0781,5061,4371,442
Total Current Liabilities
19,67214,99316,9107,12614,9417,432
Long-Term Debt
1,34611121950-14,517
Long-Term Leases
177.72234.81260.64237.74311.38338.98
Pension & Post-Retirement Benefits
368.29440.88467.427.18--
Long-Term Deferred Tax Liabilities
476.96381.42301.54---
Other Long-Term Liabilities
55.7349.3178.329.018.3742.89
Total Liabilities
22,09616,21118,2377,43015,26022,331

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,0422,0422,0422,0421,9901,867
Additional Paid-In Capital
22,00922,00922,00922,00919,10312,316
Retained Earnings
17,89217,46020,98921,44721,01920,057
Treasury Stock
-979.15-979.15-979.15-979.15-979.15-994.58
Comprehensive Income & Other
-845.33-144.41-475.25-365.24-387.2-359.74
Total Common Equity
40,11940,38743,58544,15340,74532,885
Minority Interest
-134.242,3662,0867.2289.36173.98
Shareholders' Equity
39,98442,75345,67244,16040,83533,059
Total Liabilities & Equity
62,08058,96463,90951,59156,09555,390

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
10,8859,52511,5033,71911,30617,370
Net Cash (Debt)
3,8816,8072,69421,53516,08610,341
Net Cash Growth
-5.68%152.70%-87.49%33.88%55.56%25.57%
Net Cash Per Share
199.07349.14136.701119.39860.34583.56
Filing Date Shares Outstanding
19.519.519.519.518.9817.74
Total Common Shares Outstanding
19.519.519.519.518.9817.74
Working Capital
14,16216,59616,20730,80927,03134,092
Book Value Per Share
2057.832071.612235.662264.772147.251854.08
Tangible Book Value
33,01733,08434,39642,74538,92031,322
Tangible Book Value Per Share
1693.591697.001764.272192.552051.061765.94
Land
8,6088,6088,6086,1076,1076,107
Buildings
10,76810,76810,7684,2894,2894,289
Machinery
12,73412,81313,0923,9753,7603,461
Construction In Progress
1,800-486.71459.56234.2139.81